We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Equity Crowdfunding Pitches

Showing 225 results
Carnot is developing hydrogen engines with key components manufactured from ceramics able to withstand fuel combustion temperatures, eliminating the need for cooling systems and doubling the efficiencies of modern engines. The company argues that modern engines waste on average one-third of fuel energy to cool systems that stop metallic components from melting. Carnot claims that its engines eliminate this waste doubling efficiency, halve fuel costs and CO2 and achieve net-zero operation by operating on biofuels and hydrogen benefiting the long haul transport, marine and primary off-grid power markets. Carnot has raised over £600,000 including a pre-seed round in 2020 for £357,000 at a pre-money valuation of £2 million, a £300,000 Innovate UK grant and another £300,000 Eureka Eurostar’s grant. Carnot has a 5-year, 3-phase exit strategy and will begin licensing its IP at the end of 2023 at which point it will begin generating revenue. It will eventually look for acquisition from one of its manufacturing partners in 2025 after demonstrating industry acceptance of its technology.
pledged: 66% days to go: 53 investment: £200,000
INSPHERE uses image sensors and Artificial Intelligence (AI) to guide and correct robot positioning during the manufacturing process, ensuring right-first-time production. The company argues that industrial robots are not completely accurate and can experience unplanned downtime that can cost up to £10,000 per minute. INSPHERE asserts that its solution allows factory operators to operate safely with less downtime, and with multiple robot and human operators. The company has developed three products since 2013 which have received recognition in the aerospace and industrial automation sectors. INSPHERE is now launching IONA, a network of sensors that can be permanently deployed in a manufacturing environment to monitor and control industrial robots. IONA, the company points out, uses both hardware and software to correct errors taking into account the robot and its relationship to the workpiece. INSPHERE will use the investment to diversify the reach of IONA across markets.
pledged: 81% days to go: 14 investment: £1,019,999
Advanced Blast & Ballistic Systems (ABBS) develops patented systems to counteract the forces an armoured vehicle sustains when a mine or Improvised Explosive Device (IED) explodes under it. ABBS asserts that mines and IEDs accounted for over 80% of UK and US army casualties in Iraq and Afghanistan. ABBS argues that its systems can reverse this scenario. It aspires to become a contender in the $20 billion armoured vehicle protection market. The company has been tasked by the European Union Aviation Safety Agency (EASA) and European Organisation for Civil Aviation Equipment (EUROCAE) to draft safety regulations for emergency descent arrest systems. It also holds multiple patents for its proven Vehicle Global Acceleration Mitigation (VGAM) vehicle mine protection system and has a patent pending for a Zero-Zero Crash Prevention (ZZCP) system for light aircraft and electric Vertical Takeoff and Landing (eVTOLs) systems. ABBS will use the investment for marketing, boosting R&D, and maintaining and expanding its IP/patent portfolio.
pledged: 297% days to go: Expired investment: £297,534
Viritech is an engineering company that is using F1-derived engineering to develop hydrogen powertrain solutions and related technologies for the automotive, aerospace, marine and distributed power industries. Viritech asserts that the Hydrogen Council forecasts that hydrogen will meet 18% of global energy demand by 2050. It aims to capture this demand through its technologies. Viritech argues that its location in MIRA Technology Park allows it to access R&D facilities used by major automotive manufacturers, enabling it to scale and meet the demands of every type of project. It has filed patents for graphene hydrogen fuel tanks. Viritech will use the investment to produce test hydrogen tanks, build the Apricale hypercar, complete designs for a Heavy Goods Vehicle (HGV), Sport Utility Vehicle (SUV) and a power generator, plan a larger raise and listing on AQuis Stock Exchange (AQSE) in 2022, and eventually commercialise its technology with its partner.
pledged: 265% days to go: Expired investment: £1,061,561
Caldera is a heat battery company that seeks to institutionalise zero-carbon energy solutions for the masses. Its patented breakthrough, Warmstone heat battery, can store 100kWh of heat for a standard home for 24 hours. Caldera asserts that it takes renewable energy using a flexible green tariff with prices as low as 5p/kWh and stores it as heat, providing carbon-free hot water and heating via Warmstone. The company has raised over £1.5 million through grants and investment to date, installed its first pilot Warmstone product in a family home, established a manufacturing and R&D base, and acquired the support of an energy think tank, Energy Systems Catapult. It aspires to become a contender in the estimated £3.5 billion renewable energy storage market in the European Union (EU). The company is working with König Metall to build and sell Warmstone units via approved UK installers. Caldera will use the investment to install a small number of pilot units in trial homes in 2021 before a full commercial rollout in 2022.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

pledged: 314% days to go: Expired investment: £1,572,524
Gravitricity is an energy technology company. The company uses winches to raise a heavyweight to the top of a vertical shaft to store electricity in the form of potential energy when there is excess energy on the grid. It then lowers it when required with the winch motors running as generators to transfer energy back to users on the grid. Gravitricity argues that the system can be charged and discharged multiple times a day for over 25 years. The company has built a 250kW concept demo in Edinburgh. It aims to become a contender in the energy storage market that is set to be worth $620 billion by 2040. The company has received interest from operating mines, grid companies, EV charging stations and solar developers for its technology. It is also investigating project sites in UK, Europe, the USA and South Africa. It will use the investment to complete the concept and detailed design for its prototype, develop its commercial projects portfolio, and protect its Intellectual Property (IP).

Pitch Rated

58%

Insufficient Data

rating powered by

CROWD RATING™

pledged: 283% days to go: Expired investment: £2,124,008
Advanced Blast & Ballistic Systems (ABBS) is a company that has developed globally patented systems to counteract the forces an armoured vehicle sustains when a mine or Improvised Explosive Device (IED) explodes under it. ABBS asserts that mines and IEDs accounted for over 80% of UK and US army casualties in Iraq and Afghanistan. ABBS aims to change this and become a major contender in the $20 billion armoured vehicle protection market. The company points out that it has been tasked by the European Union Aviation Safety Agency (EASA) and European Organisation for Civil Aviation Equipment (EUROCAE) to draft safety regulations for emergency descent arrest systems. The company also holds multiple patents for its proven Vehicle Global Acceleration Mitigation (VGAM) vehicle mine protection system and has a patent pending for a Zero-Zero Crash Prevention (ZZCP) system for light aircraft and electric Vertical Takeoff and Landing (eVTOLs) systems. It will use the investment for marketing, boosting R&D, and maintaining and expanding its IP/patent portfolio.
pledged: 88% days to go: Expired investment: £88,003
Viritech is a clean technology engineering company that is using F1-derived engineering to develop hydrogen powertrain solutions and related technologies for the automotive, aerospace, marine and distributed power industries. Viritech asserts that the Hydrogen Council forecasts that hydrogen will meet 18% of global energy demand by 2050. It aims to capture this demand through its technologies. Viritech argues that its location in MIRA Technology Park allows it access to R&D facilities used by many of the world's major automotive manufacturers, allowing it to scale its resources to meet the demands of every type of project. Viritech will use the investment to produce test hydrogen tanks, build the Apricale hypercar, complete designs for a Heavy Goods Vehicle (HGV), Sport Utility Vehicle (SUV) and a power generator, plan a larger raise and listing on AQuis Stock Exchange (AQSE) in 2022, and eventually commercialise its technology with its partner.
pledged: 181% days to go: Expired investment: £726,807
Gravitricity is an energy technology company that uses heavyweights to store energy underground. The company uses winches to raise a heavyweight to the top of a vertical shaft to store electricity in the form of potential energy when there is excess energy on the grid. It then lowers it when required with the winch motors running as generators to transfer energy back to users on the grid. Gravitricity argues that the system can be charged and discharged multiple times a day for over 25 years. The company has built a 250kW concept demo in Edinburgh. It aims to become a contender in the energy storage market that is predicted to become a $620 billion market by 2040. The company has received interest from operating mines, grid companies, EV charging stations and solar developers for its technology. It will use the investment to complete the concept and detailed design for its prototype, develop its commercial projects portfolio, and protect its Intellectual Property (IP).
pledged: 158% days to go: Expired investment: £1,185,207
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
pledged: 102% days to go: Expired investment: £357,179
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph